Immunization for Alzheimer's disease: yet closer to clinical trials.
Gurwitz
D
D
gurwitz@post.tau.ac.il
D000544:Alzheimer Disease / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D016229:Amyloid beta-Peptides / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D012995:Solubility; D014611:Vaccination / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects / Q000276:immunology
D016229:Amyloid beta-Peptides; D014612:Vaccines